Open-Label, One Arm Pilot Investigation of Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas.
Phase of Trial: Phase II
Latest Information Update: 19 Apr 2012
At a glance
- Drugs Lenalidomide (Primary)
- Indications Peripheral T-cell lymphoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 18 Dec 2009 Actual patient number (1) added as reported by ClinicalTrials.gov.